ACSL1 Aggravates Thromboinflammation by LPC/LPA Metabolic Axis in Hyperlipidemia Associated Myocardial Ischemia‐Reperfusion Injury

ACSL1 Aggravates Thromboinflammation by LPC/LPA Metabolic Axis in Hyperlipidemia Associated Myocardial Ischemia‐Reperfusion Injury

Abstract Acute myocardial infarction (AMI) is associated with well‐established metabolic risk factors, especially hyperlipidemia and obesity. Myocardial ischemia‐reperfusion injury (mIRI) significantly offsets the therapeutic efficacy of revascularization. Previous studies indicated that disrupted l...

Full description

Saved in:

Bibliographic Details
Main Authors:	Shuai Jiang, Xueguang Lin, Bo Chen, Gang Chen, Kristine J.S. Kwan, Jing Liu, Qi Sun, Jie Wang, Yijie Lu, Jindong Tong, Ying Deng, Bo Yu, Jingdong Tang
Format:	Article
Language:	English
Published:	Wiley 2025-03-01
Series:	Advanced Science
Subjects:	ACSL1 hyperlipidemia ischemia‐reperfusion injury lipid metabolism thromboinflammation
Online Access:	https://doi.org/10.1002/advs.202406359
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Thromboinflammation in oncogynecological patients
by: E. V. Slukhanchuk, et al.
Published: (2022-11-01)

Thromboinflammation vs. immunothrombosis: strategies for overcoming anticoagulant resistance in COVID-19 and other hyperinflammatory diseases. Is ROTEM helpful or not?
by: Lou M. Almskog, et al.
Published: (2025-06-01)

Inhibition of SARS‐CoV‐2‐mediated thromboinflammation by CLEC2.Fc
by: Pei‐Shan Sung, et al.
Published: (2023-05-01)

The concept of thromboinflammation underlying thrombotic complications, tumor progression and metastasis in gynecological cancer patients
by: A. D. Makatsariya, et al.
Published: (2024-09-01)

Coronavirus disease 2019 (COVID-19) and immune-mediated inflammatory rheumatic diseases: at the crossroads of thromboinflammation and autoimmunity
by: E. L. Nasonov, et al.
Published: (2020-09-01)

Fetal systemic inflammatory response syndrome, thromboinflammation and neonatal septic shock: pathogenesis, diagnostics and treatment
by: V. O. Bitsadze, et al.
Published: (2025-05-01)

COP1 drives renal cell carcinoma progression by targeting ACSL4 for ubiquitin-mediated degradation and inhibiting ferroptosis
by: Yuxiao Zheng, et al.
Published: (2025-05-01)

Porphyromonas gingivalis aggravates alcohol-related liver injury via gut microbiome-HO-1-ACSL4-dependent ferroptosis
by: Xuezhe Feng, et al.
Published: (2025-04-01)

Neutrophil extracellular traps as markers of thromboinflammation in the pathogenesis of female genital tract and breast malignant neoplasms
by: E. V. Slukhanchuk, et al.
Published: (2022-09-01)

UBE2C-mediated ubiquitination of ACSL4 inhibits ferroptosis and promotes gastric cancer progression
by: Lei Yang, et al.
Published: (2025-08-01)

Core promoter identification and transcriptional regulation of porcine ACSL3 gene
by: Xiaomin Li, et al.
Published: (2024-12-01)

Hyperlipidemia and atherosclerosis: experimental models
by: K. I. Davletova, et al.
Published: (2025-07-01)

ACSL4 at the helm of the lipid peroxidation ship: a deep-sea exploration towards ferroptosis
by: Yulang Jiang, et al.
Published: (2025-08-01)

Low-Molecular-Weight Fucoidan Inhibits Thromboinflammation and Ameliorates Deep Vein Thrombosis via Targeting S100A8/A9
by: Yiting Feng, et al.
Published: (2025-04-01)

Histone lysine crotonylation accelerates ACSL4-mediated ferroptosis of keratinocytes via modulating autophagy in diabetic wound healing
by: Fengjuan Li, et al.
Published: (2025-03-01)

ACSL4 predicts rapid kidney function decline in patients with diabetic kidney disease
by: Rui Shen, et al.
Published: (2025-03-01)

Role of Hippo/ACSL4 axis in ferroptosis-induced pericyte loss and vascular dysfunction in sepsis
by: Yiyan Liu, et al.
Published: (2024-12-01)

Moxibustion ameliorates abnormal subchondral bone remodeling by promoting ACSL1-mediated autophagy to degrade NLRP3 in osteoarthritis
by: Xuelan Chen, et al.
Published: (2025-08-01)

GABPA inhibits tumorigenesis in clear cell renal cell carcinoma by regulating ferroptosis through ACSL4
by: Yaqian Wu, et al.
Published: (2024-11-01)

SUMO2 inhibits ACSL3 protein degradation to antagonize erastin-induced ferroptosis in hepatocellular carcinoma
by: Yanxi Shen, et al.
Published: (2025-06-01)

Transcription factor MEF2D regulates aberrant expression of ACSL3 and enhances sorafenib resistance by inhibiting ferroptosis in HCC
by: Xue Li, et al.
Published: (2024-12-01)

Activated TBK1 promotes ACSL1-mediated microglia lipid droplet accumulation and neuroinflammation in Parkinson’s disease
by: Chunlei Han, et al.
Published: (2025-07-01)

Parkin inhibits iron overload-induced cardiomyocyte ferroptosis by ubiquitinating ACSL4 and modulating PUFA-phospholipids metabolism
by: Dandan Xiao, et al.
Published: (2025-03-01)

EFFICIENCY AND SAFETY ASSESSMENT OF GENERIC ATORVASTATINE IN PATIENTS WITH HYPERLIPIDEMIA
by: J. E. Semyonova, et al.
Published: (2015-12-01)

RBM15 promotes hypoxia/reoxygenation-induced ferroptosis in human cardiomyocytes by mediating m6A modification of ACSL4
by: Yi Cheng, et al.
Published: (2025-07-01)

Salivary gland protective and antiinflammatory effects of genistein in Sjögren’s syndrome by inhibiting Xist/ACSL4-mediated ferroptosis following binding to estrogen receptor-alpha
by: Tianjiao Mao, et al.
Published: (2024-12-01)

ACSL4 knockdown inhibits colorectal cancer progression through stimulating anti-tumor immunity
by: Yiming Liu, et al.
Published: (2025-09-01)

Safety and Efficacy of Inclisiran in Hyperlipidemia: An Updated Meta‐Analysis of Randomised Controlled Trials
by: Jawad Basit, et al.
Published: (2025-03-01)

MiR-26a Inhibits Porcine Adipogenesis by Regulating ACADM and ACSL1 Genes and Cell Cycle Progression
by: Dongjie Zhang, et al.
Published: (2024-12-01)

Do symptoms arise from hyperlipidemia due to hyperviscosity or through its atherosclerotic consequences? – A case series exploration
by: Amit Chakraborty, et al.
Published: (2025-08-01)

Mycophenolate mofetil–induced hyperlipidemia with cutaneous manifestations
by: Rebecca M. Yim, et al.
Published: (2023-03-01)

Lipid droplet accumulation impairs osseointegration by disturbing the osteogenesis-osteoclasis balance on titanium implant surface in hyperlipidemia
by: Ya-nan Wang, et al.
Published: (2025-05-01)

Deciphering mitochondrial dysfunction in keratoconus: Insights into ACSL4 from machine learning-based bulk and single-cell transcriptome analyses and experimental validation
by: Yuchen Cai, et al.
Published: (2025-01-01)

Occurrence of hyperlipidemia in relation to body mass index in school children aged 9–11
by: Łukasz Szternel, et al.
Published: (2015-12-01)

Research Progress and Prospects of Flavonoids in the Treatment of Hyperlipidemia: A Narrative Review
by: Xingtong Chen, et al.
Published: (2025-07-01)

Circ_0124346 facilitates cell proliferation of pancreatic adenocarcinoma cells by regulating lipid metabolism via miR-223-3p/ACSL3 axis
by: Meng-lu Shu, et al.
Published: (2024-11-01)

Glycolysis‐Derived Lactate Induces ACSL4 Expression and Lactylation to Activate Ferroptosis during Intervertebral Disc Degeneration
by: Kaiqiang Sun, et al.
Published: (2025-06-01)

YTHDF2 influences hepatic fibrosis by regulating ferroptosis in hepatic stellate cells by mediating the expression of ACSL4 in an m<sup>6</sup>A-dependent manner
by: Liu Wentao, et al.
Published: (2024-12-01)

Novel advances on pathophysiological mechanisms, clinical manifestations, and treatment of antiphospholipid syndrome
by: Qing-Nan Zhu, et al.
Published: (2025-08-01)

EFFECTS OF LUDARTIN AND LEUKOMISIN ON THE ACUTE HYPERLIPIDEMIA MODEL INDUCED BY ETHANOL
by: A. V. Ratkin, et al.
Published: (2015-08-01)